Guardion Health Sciences (NASDAQ:GHSI) Releases Quarterly Earnings Results

Guardion Health Sciences (NASDAQ:GHSI) announced its quarterly earnings data on Monday. The company reported ($0.14) EPS for the quarter, Bloomberg Earnings reports. The firm had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 687.43% and a negative return on equity of 212.45%.

Shares of Guardion Health Sciences stock traded down $0.37 during trading on Tuesday, hitting $0.22. 90,066 shares of the stock traded hands, compared to its average volume of 2,061,312. The company has a current ratio of 0.35, a quick ratio of 0.15 and a debt-to-equity ratio of 0.27. The business has a fifty day simple moving average of $1.20. Guardion Health Sciences has a 52 week low of $0.56 and a 52 week high of $4.00.

Guardion Health Sciences Company Profile

Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Read More: How Investors Can Profit from Options Trading

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.